Annual Shareholders Equity
$22.89 M
-$72.83 M-76.09%
31 December 2023
Summary:
Finch Therapeutics annual stockholders equity is currently $22.89 million, with the most recent change of -$72.83 million (-76.09%) on 31 December 2023. During the last 3 years, it has risen by +$118.60 million (+123.91%). FNCH annual shareholders equity is now -88.68% below its all-time high of $202.22 million, reached on 31 December 2021.FNCH Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Shareholders Equity
$14.22 M
-$4.82 M-25.31%
30 June 2024
Summary:
Finch Therapeutics quarterly stockholders equity is currently $14.22 million, with the most recent change of -$4.82 million (-25.31%) on 30 June 2024. Over the past year, it has dropped by -$11.59 million (-44.92%). FNCH quarterly shareholders equity is now -94.06% below its all-time high of $239.46 million, reached on 31 March 2021.FNCH Quarterly Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
FNCH Shareholders Equity Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -76.1% | -44.9% |
| 3 y3 years | +123.9% | -93.5% |
| 5 y5 years | - | - |
FNCH Shareholders Equity High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -88.7% | +123.9% | -93.5% | at low |
| 5 y | 5 years | -88.7% | +123.9% | -94.1% | +114.9% |
| alltime | all time | -88.7% | +123.9% | -94.1% | +114.9% |
Finch Therapeutics Shareholders Equity History
| Date | Annual | Quarterly |
|---|---|---|
| June 2024 | - | $14.22 M(-25.3%) |
| Mar 2024 | - | $19.04 M(-16.8%) |
| Dec 2023 | $22.89 M(-76.1%) | $22.89 M(-11.3%) |
| Sept 2023 | - | $25.81 M(-7.5%) |
| June 2023 | - | $27.89 M(-15.3%) |
| Mar 2023 | - | $32.95 M(-65.6%) |
| Dec 2022 | $95.71 M | $95.71 M(-20.8%) |
| Sept 2022 | - | $120.87 M(-24.0%) |
| Date | Annual | Quarterly |
|---|---|---|
| June 2022 | - | $159.09 M(-11.5%) |
| Mar 2022 | - | $179.79 M(-11.1%) |
| Dec 2021 | $202.22 M(-311.3%) | $202.22 M(-8.0%) |
| Sept 2021 | - | $219.80 M(-3.7%) |
| June 2021 | - | $228.19 M(-4.7%) |
| Mar 2021 | - | $239.46 M(-350.2%) |
| Dec 2020 | -$95.72 M(+60.8%) | -$95.72 M |
| Dec 2019 | -$59.53 M | - |
FAQ
- What is Finch Therapeutics annual stockholders equity?
- What is the all time high annual shareholders equity for Finch Therapeutics?
- What is Finch Therapeutics annual shareholders equity year-on-year change?
- What is Finch Therapeutics quarterly stockholders equity?
- What is the all time high quarterly shareholders equity for Finch Therapeutics?
- What is Finch Therapeutics quarterly shareholders equity year-on-year change?
What is Finch Therapeutics annual stockholders equity?
The current annual shareholders equity of FNCH is $22.89 M
What is the all time high annual shareholders equity for Finch Therapeutics?
Finch Therapeutics all-time high annual stockholders equity is $202.22 M
What is Finch Therapeutics annual shareholders equity year-on-year change?
Over the past year, FNCH annual stockholders equity has changed by -$72.83 M (-76.09%)
What is Finch Therapeutics quarterly stockholders equity?
The current quarterly shareholders equity of FNCH is $14.22 M
What is the all time high quarterly shareholders equity for Finch Therapeutics?
Finch Therapeutics all-time high quarterly stockholders equity is $239.46 M
What is Finch Therapeutics quarterly shareholders equity year-on-year change?
Over the past year, FNCH quarterly stockholders equity has changed by -$11.59 M (-44.92%)